Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 196.69M P/E - EPS this Y 1.00% Ern Qtrly Grth -
Income -121.83M Forward P/E -1.84 EPS next Y 19.00% 50D Avg Chg -23.00%
Sales - PEG -0.07 EPS past 5Y - 200D Avg Chg -37.00%
Dividend N/A Price/Book 1.02 EPS next 5Y 30.10% 52W High Chg -58.00%
Recommedations 3.00 Quick Ratio 10.67 Shares Outstanding 42.07M 52W Low Chg 5.00%
Insider Own 6.93% ROA -33.19% Shares Float 13.62M Beta 1.50
Inst Own 73.75% ROE -56.34% Shares Shorted/Prior 604.04K/643.17K Price 3.75
Gross Margin - Profit Margin - Avg. Volume 123,214 Target Price 5.80
Oper. Margin - Earnings Date May 6 Volume 92,522 Change 1.63%
About Prelude Therapeutics Incorporat

Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT1419, a myeloid cell leukemia-1 inhibitor, which is in Phase 1 clinical trial for the treatment of selected relapsed/refractory myeloid or B-cell malignancies; PRT2527, a cyclin-dependent kinase, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; PRT3645, a cyclin-dependent kinase 4/6 inhibitor, which is in Phase 1 clinical trial for the treatment of advanced and metastatic solid tumors; and PRT3879, a SMARCA2 selective protein degrader, which is in Phase 2/3 clinical trial for the treatment of advanced and metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.

Prelude Therapeutics Incorporat News
04/13/24 Several Insiders Invested In Prelude Therapeutics Flagging Positive News
04/09/24 Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
03/05/24 Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
02/29/24 Prelude Therapeutics to Participate in Barclays Global Healthcare Conference
02/17/24 Here's Why We're Watching Prelude Therapeutics' (NASDAQ:PRLD) Cash Burn Situation
02/15/24 Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
01/14/24 Prelude Therapeutics Incorporated (NASDAQ:PRLD) is definitely on the radar of hedge funds investors who own 33% of the company
01/02/24 Shell (SHEL) Resumes LNG Loading From Prelude Facility
12/11/23 Prelude Therapeutics Announces $25 Million Private Placement
11:46 AM Shell's (SHEL) Prelude LNG Facility to Restart in December
11/05/23 Prelude Therapeutics Insiders Are Down US$149k But Regain Some Losses
11/03/23 Q3 2023 Abcellera Biologics Inc Earnings Call
11/03/23 Prelude Therapeutics Inc (PRLD) Reports Q3 Financial Results and Strategic Pipeline Progress
11/01/23 Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results
11/01/23 Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
10/14/23 Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference
10/04/23 All You Need to Know About Prelude Therapeutics Incorporated (PRLD) Rating Upgrade to Buy
08/29/23 Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
08/17/23 10 Healthcare Stocks with Insider Buying
08/03/23 Prelude Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
PRLD Chatroom

User Image LabPsycho Posted - 2 days ago

$PRLD Looking at 5yr and 3yr chart it seems every time there is a big sell off like what occurred the past couple weeks, the following trend is down.

User Image LabPsycho Posted - 1 week ago

$PRLD Yikes...this thing is falling off a cliff disproportionate to other biotechs. It never made sense to me stock going up after Baker Bros wanting to dump. Looking at chart this could get in the 2's real quick. Is something up?

User Image LabPsycho Posted - 1 week ago

$PRLD Maybe ARVN only getting about $150M for one of their PROTAC a week ago triggered the sell off here (beyond the overall biotech implosion)?

User Image exp8triot Posted - 1 week ago

@LabPsycho what does this have to do with $Prld ?

User Image LabPsycho Posted - 1 week ago

$PRLD CFO resigning in other biotech seems to precede a long drip down in the share price

User Image exp8triot Posted - 1 week ago

$PRLD on the upswing...can be a strong candidate for a buyout with its recent clinical data results...they have many potential best in class..gonna be a really big year for this stock

User Image exp8triot Posted - 2 weeks ago

$PRLD time to fly

User Image AceAri Posted - 2 weeks ago

$PRLD Sneaky movement today. In my opinion it feels like someone is silently loading without triggering a run… This is my opinion of course. Please do your own due diligence.

User Image Turkeycock Posted - 2 weeks ago

$PRLD let's see where this goes

User Image AceAri Posted - 2 weeks ago

$PRLD the more I do my research the more I think to myself we will wake up one day and this will be in the double digits. This is my opinion, please do your research.

User Image AceAri Posted - 2 weeks ago

$PRLD https://finance.yahoo.com/news/prelude-highlights-continued-strength-discovery-203500777.html

User Image exp8triot Posted - 2 weeks ago

$MRNA check out $prld pre-clinical data for cancer. This should fly today $15+

User Image exp8triot Posted - 2 weeks ago

$PRLD man, this should FLY today. $15+ excellent clinical data

User Image Stock_Titan Posted - 2 weeks ago

$PRLD Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting https://www.stocktitan.net/news/PRLD/prelude-highlights-continued-strength-of-discovery-engine-at-2024-nfiyp7qo7k9l.html

User Image AceAri Posted - 3 weeks ago

$PRLD This is an under the radar ticker. Once this really picks up eyes it will be its true worth. This is my opinion. $10+

User Image tarak4u Posted - 4 weeks ago

$PRLD breaking out of the 50 ema onthe weekly

User Image AceAri Posted - 1 month ago

My top 3 holdings: $VERI $10+ $PRLD $10+ $OMGA $6+ This all based on my research and opinion. Please do your due diligence.

User Image AceAri Posted - 1 month ago

$PRLD this is an undervalued gem. Wait until this picks up popularity. This is my opinion, please do your research! $10+

User Image DailyStocksPicks Posted - 1 month ago

$AMLX: Significant volatility and a sharp price decline were triggered by the failure of a late-stage ALS trial for its drug Relyvrio, leading to halted promotions and negatively impacting investor sentiment and stock valuation. $LFCR, $ZVRA, $PRLD, $ME For Detailed $AMLX Analysis Watch: https://youtu.be/_2AzeWeByGY

User Image AceAri Posted - 1 month ago

$PRLD JMP Securities initiates coverage with a Market Outperform rating and announces price target of $7.

User Image AceAri Posted - 1 month ago

$PRLD this is all you need to see. This has so much potential. The set up is ready in my opinion. Please do your research.

User Image Stock_Titan Posted - 1 month ago

$PRLD Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting https://www.stocktitan.net/news/PRLD/prelude-announces-acceptance-of-multiple-preclinical-abstracts-at-nwru5gma3hao.html

User Image Ninja_Tradez Posted - 1 month ago

$PRLD You see why Ninja Bot Alerts are Import to get early ! Never Miss any alert 🚨Check Discord Link 🔗 on bio

User Image Stock_Titan Posted - 02/29/24

$PRLD Prelude Therapeutics to Participate in Barclays Global Healthcare Conference https://www.stocktitan.net/news/PRLD/prelude-therapeutics-to-participate-in-barclays-global-healthcare-lumisyxsal4q.html

User Image AceAri Posted - 2 months ago

My largest positions: $VINC $PRLD $ALLK These have so much potential in my opinion. Of course please do your research and due diligence!

User Image AnomalyDetective Posted - 2 months ago

Week 8 MDA picks ending the week up over +8% for members led by $GYRE +33% and $PRLD up +10.2% with all new Week 9 picks released in advance to members today already up +3.9% with daily breakout picks here: vmbreakouts.com and many more portfolio selection here: https://t.co/KYh2p2mD5d

User Image AceAri Posted - 2 months ago

$PRLD Deerfield started a large position in this in their recent filing. Plus this has Baker Bros and Orbimed. Oh man oh man you haven’t seen nothing yet!

User Image LabPsycho Posted - 2 months ago

$PRLD Selling lots of shares on the way down suggests another garden variety biogrifter wealth transfer vehicle to me.

User Image AceAri Posted - 2 months ago

$PRLD and $VINC will go bonkers. Watch for these two and of course do your DD!

User Image AceAri Posted - 2 months ago

$PRLD $5+ is inevitable here.

Analyst Ratings
JMP Securities Market Outperform Mar 13, 24
HC Wainwright & Co. Neutral Feb 20, 24
Morgan Stanley Underweight Dec 19, 23
HC Wainwright & Co. Buy Nov 7, 23
HC Wainwright & Co. Buy Oct 19, 23
HC Wainwright & Co. Buy Aug 17, 23
Morgan Stanley Equal-Weight Aug 4, 23
Barclays Equal-Weight Aug 4, 23
HC Wainwright & Co. Buy Mar 17, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ORBIMED ADVISORS LLC Director Director May 22 Buy 5.75 869,565 4,999,999 10,119,756 05/24/23
Bonita David P Director Director May 22 Buy 5.75 869,565 4,999,999 10,119,756 05/24/23
Huang Jane President, CMO President, CMO Apr 04 Sell 6.12 13,280 81,274 24,220 04/06/23
Chardonnet Laurent Chief Financial Offi.. Chief Financial Officer Dec 08 Buy 4.76 10,000 47,600 35,873 12/12/22
Combs Andrew EVP, Head of Chemist.. EVP, Head of Chemistry Mar 31 Option 1.89 36,062 68,157 304,442 04/04/22
Morosini Deborah EVP, Chief of Clinic.. EVP, Chief of Clinical Affairs Nov 16 Option 12.85 28,751 369,450 29,195 11/18/21
Morosini Deborah EVP, Chief of Clinic.. EVP, Chief of Clinical Affairs Nov 16 Sell 16.15 28,751 464,329 444 11/18/21
Mauro David J Chief Medical Office.. Chief Medical Officer Sep 09 Option 1.89 15,000 28,350 15,000 09/09/21
Mauro David J Chief Medical Office.. Chief Medical Officer Sep 09 Sell 36.87 15,000 553,050 09/09/21
Pierce Christopher EVP and Chief of Bus.. EVP and Chief of Business Oper Sep 07 Sell 41.44 17,000 704,480 3,750 09/07/21
Pierce Christopher EVP and Chief of Bus.. EVP and Chief of Business Oper Sep 07 Option 12.85 17,000 218,450 20,750 09/07/21
Piper Brian Chief Financial Offi.. Chief Financial Officer Aug 27 Sell 33.33 8,333 277,739 08/27/21
Piper Brian Chief Financial Offi.. Chief Financial Officer Aug 27 Option 1.89 8,333 15,749 8,333 08/27/21